(Enzymes) Nattokinase : The Natto Fibrinolytic, Circulatory Cleaner, Blood Flow Optimizer

Nattokinase is a powerful fibrin-dissolving enzyme extracted from the traditional Japanese food natto, offering a gentle, sustained approach to supporting healthy circulation, blood viscosity, and cardiovascular resilience by targeting the root of clot formation.

---

1. Overview:

Nattokinase is a potent fibrinolytic enzyme (a subtilisin-like serine protease) produced by Bacillus subtilis natto during the fermentation of soybeans into natto. It exhibits a strong, direct, and prolonged ability to dissolve fibrin—the meshwork of blood clots—and also supports healthy blood pressure and circulation by influencing the body's own fibrinolytic system.

2. Origin & Common Forms:

Exclusively derived from natto fermentation. Available in capsules, often enteric-coated for stability, and standardized by fibrinolytic activity (FU - Fibrinolytic Units).

3. Common Supplemental Forms: Standard & Enhanced

· Enteric-Coated Nattokinase Capsules: The standard form, protecting the enzyme from stomach acid.

· Standardized Extracts: High-quality products are standardized to a specific fibrinolytic activity, typically 2000 FU (Fibrinolytic Units) per capsule.

· Combination Formulas: Sometimes combined with other circulatory supports like serratiopeptidase, pycnogenol, or vitamin K2 (MK-7).

4. Natural Origin:

· Sole Source: The traditional Japanese food natto (fermented soybeans). The enzyme is produced by the specific bacterium Bacillus subtilis natto during the fermentation process.

· Precursors: The bacterium secretes nattokinase as an extracellular enzyme.

5. Synthetic / Man-made:

· Process: Not synthetic. Produced via the fermentation of soybeans with B. subtilis natto, identical to the food process but scaled and purified for supplementation.

6. Commercial Production:

· Precursors: Non-GMO soybeans and a pure culture of Bacillus subtilis natto.

· Process: Soybeans are steamed, inoculated with the bacteria, and fermented. The fermented beans are then extracted, and the enzyme is purified through filtration, concentration, and lyophilization. The final powder is encapsulated, often with an enteric coat.

· Purity & Efficacy: The gold standard is an extract standardized to 2000 FU per 100mg. This ensures consistent, research-backed potency. Efficacy is demonstrated by its ability to reduce clotting factors and improve blood flow parameters.

7. Key Considerations:

A Food-Based Enzyme with Drug-Like Effects. Nattokinase offers a unique, food-sourced approach to fibrinolysis with a long duration of action (8-12 hours). It works by directly degrading fibrin and also by converting endogenous prourokinase to urokinase and degrading plasminogen activator inhibitor-1 (PAI-1), enhancing the body's natural clot-dissolving system.

8. Structural Similarity:

A serine protease of the subtilisin family. It is structurally distinct from the mammalian enzyme plasmin but mimics its fibrin-digesting action.

9. Biofriendliness:

· Utilization: Absorbed intact from the intestine when enteric-coated. Orally active and can be detected in the blood several hours after ingestion.

· Metabolism & Excretion: Its enzymatic activity gradually declines in circulation. Cleared by the body's metabolic processes.

· Toxicity: Very low. Long-term consumption of natto in Japan suggests an excellent safety profile.

10. Known Benefits (Clinically Supported):

· Fibrinolytic & Anti-Thrombotic Activity: Reduces blood clot formation potential, lowers elevated levels of fibrinogen, Factor VII, and Factor VIII.

· Supports Healthy Blood Pressure: Clinical trials show it can reduce systolic and diastolic blood pressure in hypertensive individuals.

· Improves Blood Flow & Viscosity: Reduces plasma viscosity and improves markers of circulation.

· May Support Atherosclerosis Regression: By dissolving the fibrin mesh within arterial plaques, it may help reduce plaque size and instability.

11. Purported Mechanisms:

· Direct Fibrinolysis: Cleaves cross-linked fibrin directly, dissolving existing thrombi.

· Enhanced Endogenous Fibrinolysis: Increases the production of tissue plasminogen activator (t-PA) and converts prourokinase to active urokinase.

· Inhibition of Clotting Factors: Reduces the activity of plasma levels of fibrinogen and coagulation factors.

· PAI-1 Degradation: Breaks down Plasminogen Activator Inhibitor-1, a primary inhibitor of clot dissolution.

12. Other Possible Benefits Under Research:

· Prevention of deep vein thrombosis (DVT) during long-haul flights.

· Support for fibromyalgia and chronic fatigue syndrome (via improved microcirculation).

· Potential neuroprotective effects in stroke.

· Reduction of varicose vein symptoms.

13. Side Effects:

· Minor & Transient: Rare. May include mild gastrointestinal upset, headache, or dizziness.

· To Be Cautious About: Bleeding Risk: The primary concern, especially when combined with other blood-thinning agents.

14. Dosing & How to Take:

· Standard Maintenance Dose: 100 mg (2000 FU), taken on an empty stomach, once or twice daily.

· For Targeted Support: Doses up to 4000 FU (200 mg) daily have been used in studies.

· How to Take: With water, on an empty stomach (at least 1 hour before or 2 hours after food) for optimal absorption. Often taken at bedtime due to its prolonged action and higher nighttime risk of clotting events.

15. Tips to Optimize Benefits:

· Consistency: Its effects are cumulative and best with daily use.

· Synergistic Combinations: Vitamin K2 (MK-7): For comprehensive cardiovascular health (calcium direction + fibrin clearance). Garlic Extract & Omega-3s: For multi-modal antiplatelet and anti-inflammatory support.

· Lifestyle: Pair with adequate hydration, a healthy diet, and regular movement for optimal circulatory health.

16. Not to Exceed / Warning / Interactions:

· Drug Interactions (CRITICAL): Anticoagulants/Antiplatelets (Warfarin, Aspirin, Clopidogrel, DOACs): High risk of serious bleeding. Contraindicated unless under strict medical supervision. NSAIDs & Herbs (Ginkgo, Garlic, Ginger): Additive bleeding risk.

· Medical Conditions: Bleeding Disorders, Active Ulcers, Upcoming Surgery (discontinue 1-2 weeks prior), History of Hemorrhagic Stroke: Contraindicated. Pregnancy/Lactation: Avoid.

17. LD50 & Safety:

· Acute Toxicity (LD50): Not established; considered very low.

· Human Safety: Excellent in human clinical trials. No significant adverse effects at recommended doses.

18. Consumer Guidance:

· Label Literacy: Look for standardization to Fibrinolytic Units (FU). A standard dose is 100mg providing 2000 FU. The "NSK-SD®" stamp indicates a specific, well-studied patented form.

· Quality Assurance: Choose brands that use third-party testing to verify potency and the absence of contaminants like vitamin K1 (which could interfere with anticoagulant therapy).

· Manage Expectations: It is a powerful circulatory supporter, not an acute blood thinner like a drug. Effects on blood pressure and clotting factors develop over weeks of consistent use. It is a preventative and longevity-supporting nutrient.